Citations 170

Proceedings of the 43nd Annual Upper Midwest Neuro-Ophthalmology Group Meeting, July 23, 2021 and Second Virtual Upper Midwest Neuro-Ophthalmology Group Meeting

Neuro-Ophthalmology | October 13, 2021 | Volume: 45 | Issue: 6 | Pages: 411-416

10.1080/01658107.2021.1981948 | PMID 34720274

Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis

Neuro-Ophthalmology | August 20, 2021 | Volume: 46 | Issue: 2 | Pages: 75-79

10.1080/01658107.2021.1965627 | PMID 35273408

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies

Neurology | August 13, 2021 | Volume: 97 | Issue: 13 | Pages: No page available

10.1212/wnl.0000000000012599 | PMID 34389648

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

Neurology | July 14, 2021 | Volume: 97 | Issue: 11 | Pages: No page available

10.1212/wnl.0000000000012467 | PMID 34261784

Postcataract Surgery Anterior Ischemic Optic Neuropathy

Journal of Neuro-Ophthalmology | May 18, 2021 | Volume: 42 | Issue: 1 | Pages: e453-e454

10.1097/wno.0000000000001257 | PMID 34001740

Optic chiasm involvement in AQP-4 antibody–positive NMO and MOG antibody–associated disorder

Multiple Sclerosis Journal | May 12, 2021 | Volume: 28 | Issue: 1 | Pages: 149-153

10.1177/13524585211011450 | PMID 33975499

Background: Optic neuritis (ON) is often the presenting symptom in inflammatory central nervous system demyelinating disorders. Objective: To compare the frequency and pattern of optic chiasm involvement in patients with aquaporin-4-immunoglobulin G (AQP4-IgG)-associated ON to patients with myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated ON. Methods: Retrospective review of all patients evaluated at Mayo Clinic, Stanford University and Ramathibodi Hospital who were found to have: (1) ON, (2) either MOG-IgG or AQP4-IgG by cell-based assay, and (3) magnetic resonance imaging (MRI) at the time of ON. MRI was reviewed for contrast enhancement of the optic chiasm and the pattern of involvement. Results: One hundred and fifty-four patients (74 AQP4-IgG and 80 MOG-IgG) were included. Among patients with AQP4-IgG-ON, 20% had chiasmal involvement, compared with 16% of patients with MOG-IgG-ON ( p = 0.66). In patients with chiasmal involvement, longitudinally extensive optic nerve enhancement (from orbit extending to chiasm) was identified in 54% of MOG-IgG-ON patients, compared with 7% of AQP4-IgG-ON patients ( p = 0.01). Conclusion: Chiasmal involvement of MOG-IgG-ON and AQP4-IgG-ON occur at more similar frequencies than previously reported. Furthermore, MOG-IgG-ON chiasmal involvement is more likely to be part of a longitudinally extensive optic nerve lesion.
Detection of Asymptomatic Radiation Induced Optic Neuropathy with Optical Coherence Tomography

Neuro-Ophthalmology | May 3, 2021 | Volume: 45 | Issue: 5 | Pages: 339-342

10.1080/01658107.2020.1871031 | PMID 34566215

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

JAMA Neurology | April 26, 2021 | Volume: 78 | Issue: 6 | Pages: 741

10.1001/jamaneurol.2021.0912 | PMID 33900394

Clinical Utility of Antiretinal Antibody Testing

JAMA Ophthalmology | April 22, 2021 | Volume: 139 | Issue: 6 | Pages: 658

10.1001/jamaophthalmol.2021.0651 | PMID 33885761

MOG-IgG Among Participants in the Pediatric Optic Neuritis Prospective Outcomes Study

JAMA Ophthalmology | March 25, 2021 | Volume: 139 | Issue: 5 | Pages: 583

10.1001/jamaophthalmol.2021.0349 | PMID 33764379